Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, Abbott Expand Alliance to Include Artus Infectious Disease Assays

NEW YORK, June 23 (GenomeWeb News) - Qiagen and Abbott have extended an existing distribution agreement, the companies said yesterday.

 

Terms of the original agreement gave Abbott distribution rights to an undisclosed number of real-time PCR diagnostic tests for use on Applied Biosystems detection instruments. The PCR assays were developed by Artus, a company Qiagen recently acquired.


Under the extended agreement, Abbott will have non-exclusive distribution rights to certain other Qiagen products, including infectious disease tests for hepatitis B, Epstein-Barr virus, Varicella-Zoster virus, Parvo B19 virus, cytomegalovirus, herpes simplex virus, and enterovirus. These products "complement" tests developed and manufactured by Abbott and Celera Diagnostics, Qiagen said in a statement.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.